As of Oct 12, 2026 close
- Market cap
- $7.99M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.05$3.50
- Volume (live)
- -
- Avg. volume (3M)
- 120.69K
Chemomab Therapeutics (CMMB) Stock Price & Financial Analysis
Chemomab Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.38 - $1.46 |
|---|---|
| 52-Week High | $3.50 |
| 52-Week Low | $1.05 |
| Open | $1.38 |
| Volume (last close) | 17.20K |
| Average Volume (3M) | 120.69K |
| Market Cap | 7.99M |
|---|---|
| Shares Outstanding | 5.75M |
| Price to Book (P/B) | 0.92 |
| EV/EBITDA | -0.25 |
| 50-Day MA | $2.11 |
|---|---|
| 200-Day MA | $1.80 |
| 1-Year Change | −58.63% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Chemomab Therapeutics at a Glance
Chemomab Therapeutics (CMMB) has a market capitalization of $7.99M.
It holds $6.00M in cash and securities against $0.00 of debt, a net cash position of $6.00M.
Chemomab Therapeutics does not currently pay a dividend.
The share price is down 58.6% over the past year. At $1.39 it sits near the bottom of its 52-week range of $1.05 to $3.50, below its 200-day moving average of $1.80.
Frequently Asked Questions About Chemomab Therapeutics
What is the current stock price for CMMB?
As of the Oct 12, 2026 close, CMMB stock trades at $1.39. The 52-week range is $1.05–$3.50, with a day range of $1.38–$1.46.
What is the P/E ratio for CMMB?
The P/E ratio (Price-to-Earnings) for CMMB is shown in the Key Statistics section. This valuation metric helps compare Chemomab Therapeutics Ltd. to industry peers.
Does CMMB pay dividends?
Chemomab Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for CMMB?
Analyst ratings and recommendations for CMMB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CMMB?
Chemomab Therapeutics's market capitalization is $8.0M, classifying it as a micro-cap company. Chemomab Therapeutics operates in the Healthcare sector within the Biotechnology industry.